Reporting of harms outcomes: a comparison of journal publications with unpublished clinical study reports of orlistat trials

Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence

(2015) Joanna Le Noury et al.   BMJ-British Medical Journal

Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence

(2015) Joanna Le Noury et al.   BMJ-British Medical Journal

Dissemination and publication of research findings: an updated review of related biases

(2014) F Song et al.   HEALTH TECHNOLOGY ASSESSMENT

Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: comparison of clinical study reports, trial registries, and publications

(2014) E. Maund et al.   BMJ-British Medical Journal

Reporting of harms data in RCTs: a systematic review of empirical assessments against the CONSORT harms extension

(2013) Alex Hodkinson et al.   BMJ Open

European drug agency's attempts to improve transparency stalled by legal action from two US drug companies

(2013) C. Dyer   BMJ-British Medical Journal

Restoring invisible and abandoned trials: a call for people to publish the findings

(2013) P. Doshi et al.   BMJ-British Medical Journal

Orlistat and the risk of acute liver injury: self controlled case series study in UK Clinical Practice Research Datalink

(2013) I. J. Douglas et al.   BMJ-British Medical Journal

Reporting of industry funded study outcome data: comparison of confidential and published data on the safety and effectiveness of rhBMP-2 for spinal fusion

(2013) M. A. Rodgers et al.   BMJ-British Medical Journal

Differences in Reporting of Analyses in Internal Company Documents Versus Published Trial Reports: Comparisons in Industry-Sponsored Trials in Off-Label Uses of Gabapentin

(2013) S. Swaroop Vedula et al.   PLOS MEDICINE

Completeness of Reporting of Patient-Relevant Clinical Trial Outcomes: Comparison of Unpublished Clinical Study Reports with Publicly Available Data

(2013) Beate Wieseler et al.   PLOS MEDICINE

The Imperative to Share Clinical Study Reports: Recommendations from the Tamiflu Experience

(2012) Peter Doshi et al.   PLOS MEDICINE

Reporting bias in medical research - a narrative review

(2010) Natalie McGauran et al.   Trials

Possible harms of oseltamivir—a call for urgent action

(2009) Tom Jefferson et al.   LANCET

Discontinuation due to adverse events in randomized trials of orlistat, sibutramine and rimonabant: a meta-analysis

(2009) K. Johansson et al.   Obesity Reviews